Published in J Biol Chem on April 15, 1991
Cloning and analysis of the human S13 ribosomal protein cDNA. Nucleic Acids Res (1993) 0.82
Androgen Receptor Regulates Transcription of the ZEB1 Transcription Factor. Int J Endocrinol (2011) 0.79
Characterization of a cDNA encoding ribosomal protein S16 in rice. Plant Physiol (1995) 0.77
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75
Isolation and characterization of a cDNA encoding ribosomal protein S16 from cotton (Gossypium hirsutum L.). Plant Physiol (1994) 0.75
Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol (1973) 3.45
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol (1999) 2.93
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren's syndrome. Gastroenterology (1996) 2.01
Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut (2003) 2.00
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer (2008) 1.93
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res (1994) 1.90
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med (1981) 1.85
Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene (2009) 1.85
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res (1982) 1.75
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem (1997) 1.72
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res (1998) 1.59
Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem (1997) 1.59
Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res (2001) 1.49
MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol (1998) 1.47
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Purification of human interleukin 1. J Supramol Struct (1980) 1.38
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Human T cell antigen expression by primate T cells. Science (1982) 1.35
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun (1999) 1.35
Identification of MUC1 proteolytic cleavage sites in vivo. Biochem Biophys Res Commun (2001) 1.34
Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem (1998) 1.34
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem (1996) 1.31
Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis (1993) 1.30
Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer (2000) 1.27
The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. J Biol Chem (2000) 1.26
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene (2010) 1.23
Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res (1985) 1.16
The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene (2006) 1.11
Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst (1984) 1.11
A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. FEBS Lett (1999) 1.10
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem (1998) 1.10
Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem (2000) 1.09
Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer (2001) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Dimensions of feedback in clinical teaching: a descriptive study. Acad Med (1996) 1.07
MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene (2006) 1.06
In vitro studies of the response of hamster lymphocytes to phytohemagglutinin and antigenic stimulation. J Immunol (1971) 1.06
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
The study of normal and malignant cell antigens by mixed agglutination. Cancer Res (1968) 1.05
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene (2011) 1.05
Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol (1995) 1.02
P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res (1997) 1.01
Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci (1994) 1.00
Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res (1997) 0.99
Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. J Biol Chem (1999) 0.98
Immunotherapy in patients with melanoma. Ann Surg (1973) 0.98
Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98
Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease. Cancer Treat Rep (1982) 0.98
Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines. J Immunol (1978) 0.98
Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J Biol Chem (1987) 0.98
HL-A antigenic loss in malignant transformation. J Natl Cancer Inst (1971) 0.97
Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res (1988) 0.97
Non-cognitive characteristics of medical students: entry to problem-based and lecture-based curricula. Med Educ (1996) 0.97
CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. J Immunol (1998) 0.97
Co-expression of human cancer-associated epitopes on mucin molecules. Int J Cancer (1987) 0.95
Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas (1989) 0.94
Human tumor-specific cytotoxic T cell lines generated from tumor-draining lymph node infiltrate. Transplant Proc (1988) 0.94
Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem (1999) 0.93
Production of HL-A-specific antibodies in monkeys by immunization with soluble HL-A-antigens. Transplantation (1972) 0.93
MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol (1997) 0.92
Detection and partial characterization of human thymus-leukemia antigens. J Natl Cancer Inst (1980) 0.92
Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer (2013) 0.92
Characterization of high and low molecular weight lymphocyte-activating factor (interleukin I) from P388D and J774.1 mouse macrophage cell lines. J Reticuloendothel Soc (1980) 0.92
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Int J Cancer (1988) 0.92
Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J Immunol (1997) 0.91
A simple, effective method for the construction of subtracted cDNA libraries. Genet Anal Tech Appl (1991) 0.91
Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells. Leuk Res (1982) 0.90
Long-term culture and characterization of alloreactive T-cell infiltrates from renal needle biopsies. Hum Immunol (1985) 0.89
MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. Br J Cancer (2004) 0.89
In vivo glycosylation of mucin tandem repeats. Glycobiology (2001) 0.89
The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development. Gastroenterology (1997) 0.89
Organ-specific pancreatic tumor growth properties and tumor immunity. Cancer Immunol Immunother (1999) 0.88
Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice. Int J Cancer (1999) 0.88
Polypeptide core of a human pancreatic tumor mucin antigen. Cancer Res (1990) 0.88
Structural analysis of peptide substrates for mucin-type O-glycosylation. Biochemistry (1998) 0.87
Expression of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer. J Gastroenterol (2000) 0.87
DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease. Pancreas (1988) 0.87
Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein. Biochemistry (2000) 0.87
Carbonic anhydrase in human pancreas: hypotheses for the pathophysiological roles of CA isozymes. Ann N Y Acad Sci (1999) 0.86
The development of homologous skin-sensitizing antibodies in experimental thyroiditis. Int Arch Allergy Appl Immunol (1967) 0.86
Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines. J Immunol (1975) 0.86
Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. Glycobiology (2004) 0.86
Human acute myelomonocytic leukemia: serologic studies with simian antisera. Blood (1976) 0.86
Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells. Biochem Biophys Res Commun (1994) 0.85
Calcium-activated chloride conductance in a pancreatic adenocarcinoma cell line of ductal origin (HPAF) and in freshly isolated human pancreatic duct cells. Pflugers Arch (1998) 0.85
Human cytotoxic lymphocytes reactive with pancreatic adenocarcinoma cells. Pancreas (1991) 0.85